The store will not work correctly when cookies are disabled.
N-(2-fluorophenyl)[5-(6-methylbenzothiazol-5-yl)(2-thienyl)]carboxamide
ID: ALA3729841
Chembl Id: CHEMBL3729841
PubChem CID: 66778784
Max Phase: Preclinical
Molecular Formula: C19H13FN2OS2
Molecular Weight: 368.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2scnc2cc1-c1ccc(C(=O)Nc2ccccc2F)s1
Standard InChI: InChI=1S/C19H13FN2OS2/c1-11-8-18-15(21-10-24-18)9-12(11)16-6-7-17(25-16)19(23)22-14-5-3-2-4-13(14)20/h2-10H,1H3,(H,22,23)
Standard InChI Key: RDEJYXRFEBACJU-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 368.46 | Molecular Weight (Monoisotopic): 368.0453 | AlogP: 5.72 | #Rotatable Bonds: 3 |
Polar Surface Area: 41.99 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.60 | CX Basic pKa: 2.33 | CX LogP: 5.42 | CX LogD: 5.42 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.50 | Np Likeness Score: -1.98 |
References
1. (2012) Compounds that modulate intracellular calcium, |